US28176E1082 - EW - 936853 (XNYS)
EDWARDS LIFESCIENCES CORP Aktie
74,20 USD
Aktuelle Kurse von EDWARDS LIFESCIENCES CORP
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NYSE |
EW
|
USD
|
04.12.2024 23:35
|
74,20 USD
| 70,20 USD | 5,70 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 2,96 % | 11,63 % | 7,65 % | -15,11 % | 7,26 % | -9,58 % |
Firmenprofil zu EDWARDS LIFESCIENCES CORP Aktie
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Investierte Fonds
Folgende Fonds haben in investiert: EDWARDS LIFESCIENCES CORP investiert:
Fonds | Vol. in Mio 2.333,18 | Anteil (%) 4,18 % |
Fonds | Vol. in Mio 1.934,56 | Anteil (%) 1,16 % |
Fonds | Vol. in Mio 3.396,32 | Anteil (%) 0,99 % |
Fonds | Vol. in Mio 4.003,88 | Anteil (%) 0,99 % |
Fonds | Vol. in Mio 3.510,12 | Anteil (%) 0,96 % |
Unternehmensdaten zur EDWARDS LIFESCIENCES CORP Aktie
Name EDWARDS LIFESCIENCES CORP
Firma Edwards Lifesciences Corporation
Symbol EW
Website https://www.edwards.com
Heimatbörse
NYSE
WKN 936853
ISIN US28176E1082
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO Mr. Bernard J. Zovighian
Marktkapitalisierung 42 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 19,8 T
Adresse One Edwards Way, 92614 Irvine
IPO Datum 2000-03-27
Aktien-Splits
Datum | Split |
---|---|
01.06.2020 | 3:1 |
14.12.2015 | 2:1 |
28.05.2010 | 2:1 |
27.05.2010 | 1:1 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | EWL.F |
NYSE | EW |
XETRA | EWL.DE |
Weitere Aktien
Investoren die EDWARDS LIFESCIENCES CORP die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.